Literature DB >> 3874925

Natural killer-mediated lysis of normal and malignant target cells, and its regulation by monocytes.

K Oshimi, Y Oshimi, M Satake, H Mizoguchi.   

Abstract

After depletion of monocytes, natural killer (NK) cells were partially purified from peripheral blood by Percoll density gradient sedimentation. The NK cells were then cultured for 1 d and assayed for their cytotoxicity against various types of normal and malignant target cells. All types of target cells tested were found to be susceptible to NK cells. The susceptible targets were autologous T and B lymphocytes, mitogen-induced T and B blasts, monocytes, large granular lymphocytes, autologous or allogeneic lymphoma and leukemia cells isolated from patients, and cultured cell lines, including those resistant to interferon-activated lymphocytes. Such a broad spectrum of cytotoxicity was demonstrated in 1 d of culture, and freshly prepared NK cells were not cytotoxic, or, if anything, were less cytotoxic. Monocytes and their supernatants, added throughout the course of culture, markedly inhibited the development of their cytotoxicity. These results may suggest that, although NK cells having ability to lyse autologous normal and malignant target cells are present in vivo, their lytic activity is regulated by coexisting monocytes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874925      PMCID: PMC2187751          DOI: 10.1084/jem.162.2.472

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  Modulation of natural killer (NK) cells by autologous neutrophils and monocytes.

Authors:  J Yang; D Zucker-Franklin
Journal:  Cell Immunol       Date:  1984-06       Impact factor: 4.868

2.  Preparative separation of human T cells reactive with the OKT4 monoclonal antibody.

Authors:  S M Payne; S O Sharrow; G M Shearer; W E Biddison
Journal:  Int J Immunopharmacol       Date:  1981

3.  Suppression of natural killer activity in human blood and bone marrow cultures by bone marrow-adherent OKM1-positive cells.

Authors:  C J Punjabi; M A Moore; P Ralph
Journal:  Cell Immunol       Date:  1983-04-01       Impact factor: 4.868

4.  Monocyte-induced human natural killer cell suppression followed by increased cytotoxic activity during short-term in vitro culture in autologous serum.

Authors:  M Jondal; J Merrill; M Ullberg
Journal:  Scand J Immunol       Date:  1981-11       Impact factor: 3.487

5.  In vitro enhancement of peripheral blood mononuclear cell natural killer activity following short term incubation with fetal calf serum.

Authors:  S J Lauer; J Finlan; L D Borella; V D Piaskowski; J T Casper
Journal:  J Clin Lab Immunol       Date:  1983-10

6.  Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes: requirement for reactive metabolites of oxygen.

Authors:  W E Seaman; T D Gindhart; M A Blackman; B Dalal; N Talal; Z Werb
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

7.  Inhibition of human natural killer cell activity by cytophilic immunoglobulin G.

Authors:  A Sulica; M Gherman; C Galatiuc; M Manciulea; R B Herberman
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

8.  Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo.

Authors:  J F Bukowski; B A Woda; S Habu; K Okumura; R M Welsh
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

9.  Multiple activities of a cloned cell line mediating natural killer cell function.

Authors:  G Nabel; L R Bucalo; J Allard; H Wigzell; H Cantor
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

10.  Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens.

Authors:  J H Phillips; A M Le; L L Lanier
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

View more
  12 in total

1.  Induction of activated killer cells from human lymphocytes by medullasin (a serine protease in bone marrow cells).

Authors:  Y Aoki; T Hase; K Oshimi; K Suzuki
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

2.  Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.

Authors:  H Hirofuji; S Kakumu; A Fuji; Y Ohtani; K Murase; H Tahara
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

3.  Natural killer cells in viral arthritis.

Authors:  J G Aaskov; D A Dalglish; J J Harper; J F Douglas; M D Donaldson; P J Hertzog
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

4.  Inhibition of lymphokine-activated killer cell generation by cultured tumor cell lines in vitro.

Authors:  P J Guillou; P C Sedman; C W Ramsden
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Necrosis and apoptosis associated with distinct Ca2+ response patterns in target cells attacked by human natural killer cells.

Authors:  Y Oshimi; K Oshimi; S Miyazaki
Journal:  J Physiol       Date:  1996-09-01       Impact factor: 5.182

6.  Activation of NK cells in male cancer survivors by fucoidan extracted from Cladosiphon okamuranus.

Authors:  Takeaki Nagamine; Kizuku Kadena; Makoto Tomori; Katsuyuki Nakajima; Masahiko Iha
Journal:  Mol Clin Oncol       Date:  2019-10-31

7.  Specific expression of human c-fgr in natural immunity effector cells.

Authors:  K Inoue; T Yamamoto; K Toyoshima
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

8.  Interferon-gamma (IFN-gamma) and interleukin-2 in the generation of lymphokine-activated killer cell cytotoxicity--IFN-gamma-induced suppressive activity.

Authors:  M Toledano; C Mathiot; J Michon; G Andreu; D Lando; M Brandely; W H Fridman
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

9.  Surface phenotypes of human peripheral blood mononuclear cells from patients with gastrointestinal carcinoma.

Authors:  G Boltz; E Penner; C Holzinger; S Bakos; A Fellinger; M Walgram; C Wiltschke; H Rumpold; K Langer; A Gangl
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

10.  Regulation of human natural killer (NK) cell function: induction of killing of an NK-resistant renal carcinoma cell line.

Authors:  M C Kanar; D L Thiele; M Ostensen; P E Lipsky
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.